These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11475815)

  • 41. Management of atrial fibrillation--Part 2.
    Aronow WS
    Compr Ther; 2008; 34(3-4):134-42. PubMed ID: 19137754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapy of venous and arterious circulation disorders using Melilotus].
    Mahr H
    Med Monatsschr; 1971 Jul; 25(7):334-6. PubMed ID: 5563917
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of anticoagulants and antifibrinolytic agents in the complex treatment of patients with acute pneumonia].
    Sheleg VA
    Vrach Delo; 1985 Feb; (2):110-2. PubMed ID: 3992976
    [No Abstract]   [Full Text] [Related]  

  • 44. [3 years of general embolism prophylaxis in nailed femoral neck fractures by anticoagulants].
    Staffen A; Schürer-Waldheim H
    Wien Klin Wochenschr; 1970 Oct; 82(44):793-4. PubMed ID: 5476162
    [No Abstract]   [Full Text] [Related]  

  • 45. Rate control for atrial fibrillation: one drug or two?
    Segal OR
    Postgrad Med J; 2009 Jun; 85(1004):281-2. PubMed ID: 19528299
    [No Abstract]   [Full Text] [Related]  

  • 46. Diurnal variation in the intensity of anticoagulation in atrial fibrillation.
    García A; Marín F; Sánchez B; Roldán V; Marco P
    Stroke; 2002 Jan; 33(1):322-4. PubMed ID: 11779936
    [No Abstract]   [Full Text] [Related]  

  • 47. Acenocoumarol and 6-mercaptopurine: an important drug interaction.
    Fernández MA; Regadera A; Aznar J
    Haematologica; 1999 Jul; 84(7):664-5. PubMed ID: 10406922
    [No Abstract]   [Full Text] [Related]  

  • 48. [Why should we not only try but even struggle for sinus rhythm maintenance -- cardiac surgeon's point of view].
    Suwalski P; Suwalski G
    Kardiol Pol; 2007 May; 65(5):616-8. PubMed ID: 17577858
    [No Abstract]   [Full Text] [Related]  

  • 49. Oral anticoagulants may prevent NSAID-induced urticaria.
    Asero R
    Clin Exp Dermatol; 2006 Jul; 31(4):589-90. PubMed ID: 16716169
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
    Bucerius J; Ezziddin S; Brockmann H; Palmedo H; Biersack HJ
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):606-9. PubMed ID: 17943696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

  • 52. Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
    Batcher EL; Tang XC; Singh BN; Singh SN; Reda DJ; Hershman JM;
    Am J Med; 2007 Oct; 120(10):880-5. PubMed ID: 17904459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The suppressive effect of melilotus extract on the thermal edema of rats].
    Nishikawa M; Yamashita A; Ando K; Mitsuhiro S
    Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):193-209. PubMed ID: 6862319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
    Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Schvartz C
    Arch Mal Coeur Vaiss; 2004 Mar; 97(3):207-13. PubMed ID: 15106744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).
    O'Hara GE; Charbonneau L; Chandler M; Vidaillet HJ; Philippon F; Sami M; Rocco TA; Padder FA; Champagne J; Pratt CM; Coutu B; Wyse DG;
    Am J Cardiol; 2005 Sep; 96(6):815-21. PubMed ID: 16169368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial fibrillation in the elderly.
    Fang MC; Chen J; Rich MW
    Am J Med; 2007 Jun; 120(6):481-7. PubMed ID: 17524745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Optimal approach to the treatment of atrial fibrillation in patients with chronic heart failure].
    Abuladze GV; Burdiashvili BSh; Dzhshi IM; Narsiia EV; Kantariia DA
    Georgian Med News; 2005; (124-125):44-6. PubMed ID: 16148376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.